The Complexities of Multivalvular Disease Management: Navigating Known Unknowns and Unknown Unknowns

JACC Cardiovasc Interv. 2024 Aug 26;17(16):1932-1935. doi: 10.1016/j.jcin.2024.07.010.

Authors

Abdullah Al-Abcha¹, Chia-Hao Liu², Mohamad Alkhouli³

Affiliations

¹ Department of Cardiology, Mayo Clinic School of Medicine Rochester, Minnesota, USA.
² Department of Cardiology, Mayo Clinic School of Medicine Rochester, Minnesota, USA; Division of Cardiovascular Medicine, China Medical University Hospital, Taichung, Taiwan.
³ Department of Cardiology, Mayo Clinic School of Medicine Rochester, Minnesota, USA. Electronic address: [email protected].

PMID: 39197991
DOI: 10.1016/j.jcin.2024.07.010

No abstract available

Keywords: aortic stenosis; mitral regurgitation; quality of life; transcatheter therapies; tricuspid regurgitation; valvular heart disease.

Publication types

Editorial
Introductory Journal Article

MeSH terms

Clinical Decision-Making
Heart Valve Diseases* / diagnostic imaging
Heart Valve Diseases* / physiopathology
Heart Valve Diseases* / surgery
Heart Valve Diseases* / therapy
Heart Valve Prosthesis Implantation / adverse effects
Heart Valve Prosthesis Implantation / instrumentation
Humans
Risk Factors
Treatment Outcome